Morgan Stanley Integra Lifesciences Holdings Corp Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Morgan Stanley holds 5,256,356 shares of IART stock, worth $116 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,256,356

Previous 5,498,527 4.4%

Holding current value

$116 Million

Previous $160 Million 40.39%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$17.14 - $31.74 $4.15 Million - $7.69 Million	-242,171 Reduced 4.4%	5,256,356 $95.5 Million
Q2 2024 Oct 17, 2024	BUY	$23.14 - $34.72 $13.5 Million - $20.3 Million	583,984 Added 11.88%	5,498,527 $160 Million
Q2 2024 Aug 14, 2024	BUY	$23.14 - $34.72 $13.5 Million - $20.3 Million	583,984 Added 11.88%	5,498,527 $160 Million
Q1 2024 Oct 17, 2024	SELL	$33.4 - $45.2 $19.5 Million - $26.4 Million	-583,984 Reduced 10.62%	4,914,543 $174 Million
Q1 2024 Aug 16, 2024	SELL	$33.4 - $45.2 $11.9 Million - $16.1 Million	-356,154 Reduced 6.76%	4,914,543 $174 Million
Q1 2024 May 15, 2024	SELL	$33.4 - $45.2 $11.9 Million - $16.1 Million	-356,154 Reduced 6.76%	4,914,543 $174 Million
Q4 2023 Aug 16, 2024	SELL	$34.21 - $44.59 $7.79 Million - $10.2 Million	-227,830 Reduced 4.14%	5,270,697 $230 Million
Q4 2023 Feb 13, 2024	SELL	$34.21 - $44.59 $23.2 Million - $30.2 Million	-677,945 Reduced 11.4%	5,270,697 $230 Million
Q3 2023 Nov 15, 2023	SELL	$37.8 - $45.97 $11.6 Million - $14.1 Million	-307,361 Reduced 4.91%	5,948,642 $227 Million
Q2 2023 Aug 14, 2023	SELL	$37.95 - $58.98 $12 Million - $18.7 Million	-317,007 Reduced 4.82%	6,256,003 $257 Million
Q1 2023 May 15, 2023	BUY	$52.61 - $60.49 $14.5 Million - $16.7 Million	276,245 Added 4.39%	6,573,010 $377 Million
Q4 2022 Feb 14, 2023	BUY	$42.17 - $58.6 $227 Million - $315 Million	5,372,602 Added 581.35%	6,296,765 $353 Million
Q3 2022 Nov 14, 2022	BUY	$42.28 - $57.17 $1.71 Million - $2.31 Million	40,328 Added 4.56%	924,163 $39.1 Million
Q2 2022 Oct 27, 2022	BUY	$53.86 - $66.52 $8.7 Million - $10.8 Million	161,612 Added 22.38%	883,835 $47.8 Million
Q2 2022 Aug 15, 2022	BUY	$53.86 - $66.52 $8.7 Million - $10.8 Million	161,612 Added 22.38%	883,835 $47.8 Million
Q1 2022 Oct 27, 2022	SELL	$62.86 - $69.24 $10.2 Million - $11.2 Million	-161,612 Reduced 18.29%	722,223 $46.4 Million
Q1 2022 May 13, 2022	BUY	$62.86 - $69.24 $4.04 Million - $4.45 Million	64,315 Added 9.78%	722,223 $46.4 Million
Q4 2021 Feb 14, 2022	SELL	$62.47 - $73.25 $4.75 Million - $5.56 Million	-75,960 Reduced 10.35%	657,908 $44.1 Million
Q3 2021 Nov 15, 2021	BUY	$64.97 - $76.19 $47.7 Million - $55.9 Million	733,868 New	733,868 $50.3 Million

Others Institutions Holding IART

# of Institutions

241

Shares Held

75.3M

Call Options Held

585K

Put Options Held

21.3K

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.85B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account